JP-1366 20mg tablet

DRUG2 trials

Sponsors

Onconic Therapeutics Inc.

Conditions

Healthy

Phase 1

Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy Volunteers

CompletedNCT05712681

Onconic Therapeutics Inc.Healthy

Start: 2023-03-29End: 2023-05-18Updated: 2024-08-26

Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers

CompletedNCT05814809

Onconic Therapeutics Inc.Healthy

Start: 2022-09-30End: 2022-11-09Updated: 2023-04-20